Inicio › Cáncer (todos los tipos) › Virginia › Arlington
Ensayos clínicos de Cáncer (todos los tipos) en Arlington, VA
48 estudios para Cáncer (todos los tipos) buscan participantes en centros de Arlington y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
ReclutandoFase 1/2
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
ReclutandoFase 2
- Next Virginia /ID# 279684, Fairfax · A 11 mi de distancia
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
ReclutandoFase 2
- Virginia Cancer Specialists ( Site 1102), Fairfax · A 11 mi de distancia
A Study of ASP3082 in Adults With Advanced Solid Tumors
ReclutandoFase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
REC-7735 in Participants With Solid Tumors
ReclutandoFase 1/2
- NEXT Virginia, Fairfax · A 11 mi de distancia
Registry Study for Radiation Therapy Outcomes
ReclutandoEstudio observacional
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
A Study of PHN-012 in Patients With Advanced Solid Tumors
ReclutandoFase 1
- PHN-012-001 Site, Fairfax · A 11 mi de distancia
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
ReclutandoFase 3
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
ReclutandoFase 1
- NEXT Oncology, Fairfax · A 11 mi de distancia
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
ReclutandoFase 3
- Inova Schar Cancer Institute Clinical Trials, Fairfax · A 11 mi de distancia
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
ReclutandoFase 3
- Virginia Cancer Specialists - Fairfax /ID# 280710, Fairfax · A 11 mi de distancia
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
ReclutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
ReclutandoFase 2
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
ReclutandoFase 1
- NEXT Virginia ( Site 0054), Fairfax · A 11 mi de distancia
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
ReclutandoFase 1
- Investigational Site number: 404, Fairfax · A 11 mi de distancia
A Phase 1/1b Study of IAM1363 in HER2 Cancers
ReclutandoFase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
ReclutandoFase 1
- NEXT Oncology, Fairfax · A 11 mi de distancia
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- USO - Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
ReclutandoFase 1
- NEXT Oncology, Fairfax · A 11 mi de distancia
Project: Every Child for Younger Patients With Cancer
ReclutandoEstudio observacional
- Inova Fairfax Hospital, Falls Church · A 4 mi de distancia
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
ReclutandoFase 1
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
A Study of ASP1002 in Adults for Treatment of Solid Tumors
ReclutandoFase 1
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
ReclutandoFase 2
- 522, Fairfax · A 11 mi de distancia
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
ReclutandoFase 1
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
ReclutandoFase 1
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax · A 11 mi de distancia
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
ReclutandoFase 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · A 11 mi de distancia
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · A 11 mi de distancia
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · A 11 mi de distancia
Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
ReclutandoSe aceptan voluntarios sanos
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
ReclutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- NEXT, Fairfax · A 11 mi de distancia
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
Reclutando
- Inova Schar Cancer - Saville Cancer Screening and Prevention Center, Fairfax · A 11 mi de distancia
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
ReclutandoFase 1
- Research Site, Fairfax · A 11 mi de distancia
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
ReclutandoFase 2/3
- Virginia Cancer Specialists - Fairfax /ID# 275071, Fairfax · A 11 mi de distancia
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
ReclutandoFase 1
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
ReclutandoFase 1/2
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
ReclutandoFase 1
- NEXT Oncology - Virginia, Fairfax · A 11 mi de distancia
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
ReclutandoFase 1
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
ReclutandoFase 1/2
- NEXT Oncology, Fairfax · A 11 mi de distancia
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
ReclutandoFase 1
- NEXT Virigina, Fairfax · A 11 mi de distancia
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
ReclutandoFase 1
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
ReclutandoFase 1/2
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Study in Patients With Advanced Cancers
ReclutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
Más información sobre Cáncer (todos los tipos) en MedlinePlus
Ensayos de Cáncer (todos los tipos) en otras ciudades
- Houston, TX121 estudios
- New York City, NY110 estudios
- Boston, MA86 estudios
- Los Angeles, CA73 estudios
- Nashville, TN65 estudios
- Philadelphia, PA59 estudios
- Durham, NC58 estudios
- Washington, DC58 estudios
- Chicago, IL51 estudios
- Seattle, WA49 estudios
- Atlanta, GA49 estudios
- St. Louis, MO46 estudios
Otros estudios en Arlington
- Cáncer de pulmón de células no pequeñas104 estudios
- Cáncer metastásico53 estudios
- Cáncer del colon y del recto52 estudios
- Cáncer de seno46 estudios
- Cáncer de ovario46 estudios
- Cáncer de pulmón41 estudios
- Cáncer de endometrio39 estudios
- Cáncer de páncreas33 estudios
- Carcinoma de células escamosas de cabeza y cuello26 estudios
- Cáncer de pulmón de células pequeñas23 estudios
- Cáncer de mama triple negativo20 estudios
- Cáncer de estómago20 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.